Abstracts

Highlights from the 2006 World Transplant Congress

George V. Mazariegos, MD, Children’s Hospital of Pittsburgh of UPMC's Director of Pediatric Transplantation, and colleagues from Children’s Hospital presented several key findings at the 2006 World Transplant Congress (WTC) in July. View the presentations below:

Intestinal and Multivisceral Transplantation for Patients With Abdominal Malignancy: Disease Recurrence and Survival Outcome

Early Intestinal Transplantation for Patients With Acute Irreversible Intestinal Failure

Biliary Complications After Composite Visceral Transplantation With Preservation of the Donor Duodenum

Is Histadine-Trypophan-Ketoglutarate (HTK) a Better Cold Preservative Solution for Intestinal and Multivisceral Allografts

The Role of Intestinal Reconstruction and Rehabilitation in an Intestinal Transplant Center

The Efficacy of Intravenous Immune Globulin (IVIG) in Small Bowel and Multivisceral Allografts Transplanted Across a Positive Lymphocytotoxic CrossMatch

Kidney Transplantation En-Bloc With Liver and Multivisceral Organs in Patients With Insufficient Venous Access: A Technical Challenge

Psychosocial Rehabilitation After Intestinal and Multivisceral Transplantation

Physical and Occupational Rehabilitation Before and After Intestinal Transplantation

Sustained Survival and Growth Advantages of Steroid-Free Intestinal Transplantation at 2-Year Follow-Up

Weight Gain and Obesity After Intestinal Transplantation

Steroid-Free Pediatric Intestinal Transplantation-Four-Year Experience in 75 Children

Top

Highlights from the 2005 3rd World Congress of the International Pediatric Transplant Association

Steven A. Webber, MBChB, medical director of heart and heart-lung transplant, and colleagues from Children’s Hospital of Pittsburgh presented several key findings at the 2005 annual 3rd World Congress of the International Pediatric Transplant Association (IPTA). View the presentations below:

Influence of TGF-ß1 Gene Polymorphisms on Acute and Chronic Rejection After Pediatric Heart Transplantation

Intravenous Immunoglobulin (IVIG): Effective for Reduction of Alloantibody in Sensitized Heart Transplantation (HT) Candidates

Maturity and Adherence in Adolescent Heart Recipients

Use of Molecular Testing for Cardiac Allograft Rejection Evaluation in Children: A Multicenter Study

Do Different Degrees of Low-Grade Rejection Predict Long-Term Outcomes in Pediatric Heart Transplantation?

Chronic High Epstein-Barr Virus Load Carrier State and Risk for Late Onset PTLD/ Malignant Lymphoma

Top

Highlights from the 2005 American Transplant Congress

George V. Mazariegos, MD, Children’s Hospital of Pittsburgh’s Director of Pediatric Transplantation, and colleagues from Children’s Hospital presented several key findings at the 2005 American Transplant Congress (ATC). View the presentations below:

Histadine-Tryptophan-Ketoglutarate (HTK): An Alternative Cold Perfusion and Preservation Solution for Intestinal and Multivisceral Allografts

Late Graft Loss or Death in Pediatric Liver Transplantation: Analysis of the Split Database

Rabbit Anti-Thymocyte Globulin (rATG) Induction Therapy in Pediatrics Steroid Free Liver Transplantation: One-Two Year Follow-Up

Infectious Complications with Rabbit Anti-Thymocyte Globulin (rATG) Induction Therapy in Pediatrics Steroid Free Liver Transplantation

Liver Transplantation (LT) for Maple Syrup Urine Disease (MSUD): Protocol and Preliminary Results

Pediatric Liver Transplant Recipients at ≥ 20 Years: Perceptions of Cognitive and Physical Functioning in the Long-Term Survivor

Recipient Pretreatment with Anti-Lymphocyte Antibodies and Post-Transplant Monotherapy: Success of Weaning and Long-Term Graft Function

Top

Updated 9/14/07